effect calcium antagonist isradipine capacity pulmonary function morbidity survival rate patients severe chronic obstructive pulmonary disease COPD randomized double-blind placebo-controlled study Beneficial effects calcium antagonists pulmonary haemodynamics patients chronic obstructive pulmonary disease COPD several studies Such effects decrease pulmonary vascular resistance increase cardiac output increase oxygen delivery clinical implications effects uncertain randomized double-blind placebo-controlled long-term study first clinical effects calcium antagonist patients COPD aim hypothesis calcium antagonist isradipine capacity lung function decrease morbidity mortality Fifty-two patients COPD observation period significant differences isradipine group placebo group regard parameters evidence introduction calcium antagonists part routine treatment COPD 